The Merck Global Health Innovation group is a limited liability company managing a fund of the same name looking to identify new business models and external opportunities in adjacent healthcare fields to its main medical areas, which include diabetes and vaccines.
US-based drugs company Merck has launched a $125m corporate venturing fund to build on last year’s $8.1bn internal research and development (R&D) budget.
The Merck Global Health Innovation group is a limited liability company managing a fund of the same name looking to identify new business models and external opportunities in adjacent healthcare fields to its main medical areas, which include diabetes and vaccines.
The launch follows the creation of Merck Funds in 1983 and Merck Capital Funds in 2000…
